Position history for VANGUARD GROUP INC's holdings in HALOZYME THERAPEUTICS INC
VANGUARD GROUP INC holds 11.6M shares of HALO (HALOZYME THERAPEUTICS INC), worth $778.5M as of 2025-Q4. The position was decreased (-0.5% shares). HALO represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$778.5M
Current Shares
11.6M
Total Value Change
+$40.3M
Total Shares Change
-1.3M
Other major holders of HALO: BlackRock, Inc., BlackRock Finance, Inc.
Decreased |
| 11.6M |
-0.5% |
| $778.5M |
| 0.0% |
| $67.70 |
0 |
| 2025-Q3 | Decreased | 11.6M | -5.0% | $852.9M | 0.0% | $73.29 | 0 |
| 2025-Q2 | Decreased | 12.2M | -4.6% | $637M | 0.0% | $52.21 | 0 |
| 2025-Q1 | Decreased | 12.8M | -3.4% | $818.8M | 0.0% | $63.84 | 0 |
| 2024-Q4 | Increased | 13.3M | +3.0% | $635M | 0.0% | $47.99 | 32 |
| 2024-Q3 | New | 12.9M | - | $738.1M | 0.0% | $56.97 | 44 |